Eric Shaff

Eric Shaff

Director/Miembro de la Junta en SERES THERAPEUTICS, INC. .

Fortuna: 58 153 $ al 31/07/2026

50 años
Health Technology
Consumer Services
Finance

Perfil

Eric D.
Shaff
is President, Chief Executive Officer & Director at PsiThera, Inc. since 2025.
Mr. Shaff is Director at Seres Therapeutics, Inc. since 2014.
Former roles include Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023, Principal at Pfizer Inc., Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011, Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014, and Senior Analyst at Broadview International LLC.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Johnson Graduate School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
08/07/2026 12.040 ( 0,12 % ) 58 153 $ 31/07/2026

Cargos activos de Eric Shaff

EmpresasCargoInicio
SERES THERAPEUTICS, INC. Director/Miembro de la Junta 15/01/2019

Antiguos cargos conocidos de Eric Shaff.

EmpresasCargoFin
SIGILON THERAPEUTICS, INC. Director/Miembro de la Junta 11/08/2023
MOMENTA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/11/2014
Corporate Officer/Principal 01/12/2011
PFIZER INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Eric Shaff.

Formación de Eric Shaff.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology